Skip to main content
Signal8

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention

$JAGXPress releaseJun 18, 2026, 9:00 AM ETRead the release

Jaguar Health announced that its joint venture, Magdalena Biosciences, reported positive preclinical results showing a coca leaf extract prevented weight gain in mice on a high-fat diet without reducing food intake. The extract is intended for post-GLP-1 weight loss management under FDA Botanical Guidance, addressing the unmet need of weight regain after stopping appetite-suppressing drugs.

Key figures

Drug Name
coca leaf extract
Phase Of Trial
preclinical
Funding usd
1000000
Study duration days
20

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.